QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,590 signal articles · 104 in last 24h · 108,289 total before filter · latest 33m ago
104last 24h
2558last 7d
487● bullish (7d)
230● bearish (7d)
202publishers
AllMacro227Earnings1599M&A113Regulatory15Product12Analyst26
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Sanofi Q2 Earnings Call Highlights
MarketBeat10d agoneutral
Sanofi Q2 Earnings Call Highlights

Sanofi (NASDAQ:SNY) raised its 2026 outlook after reporting double-digit second-quarter sales and earnings growth, driven by Dupixent, recently launched medicines and cost discipline. The company also increased its 2030 sales ambition for Dupixent to approximately €25 billion while outlining an ongo